A. Alayoubi

发表

Generation and Correction of a Novel Mouse Model of Farber Disease

A. Alayoubi, 2013 .

Metabolomic Study Using Time-of-Flight Mass Spectrometry Reveals Novel Urinary Biomarkers for Gaucher Disease Type 1.

C. Auray-Blais, A. Alayoubi, P. Bauer, 2022, Journal of proteome research.

Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach

G. Rivard, C. Auray-Blais, A. Alayoubi, 2020, International journal of molecular sciences.

Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus

Hesham A El-Beshbishy, F. Habib, A. Alayoubi, 2017, BMC Women's Health.

Autologous transplantation of lentivector/acid ceramidase-transduced hematopoietic cells in nonhuman primates.

D. Jaffray, J. Medin, T. Levade, 2011, Human gene therapy.

Hematopoietic stem cell transplant does not prevent neurological deterioration in infants with Farber disease: Case report and literature review

John J. Mitchell, B. Maranda, Catherine Goudie, 2019, JIMD reports.

Quantitation of a plasma biomarker profile for the early detection of Gaucher disease type 1 patients.

G. Rivard, C. Auray-Blais, A. Alayoubi, 2022, Bioanalysis.

Quantitation of a Urinary Profile of Biomarkers in Gaucher Disease Type 1 Patients Using Tandem Mass Spectrometry

C. Auray-Blais, A. Alayoubi, P. Bauer, 2022, Diagnostics.

Systemic ceramide accumulation leads to severe and varied pathological consequences

R. Hakem, J. Medin, G. Privé, 2013, EMBO molecular medicine.

The Dilemma of Transplanting Wiskott-Aldrich Syndrome Patients or not to Transplant

Al-Saud, R. Arnaout, H. Al-Mousa, 2018 .

Controlled drug release contenders comprising starch/poly(allylamine hydrochloride) biodegradable composite films.

Qingrong Huang, Abdul Ghaffar, A. Anwar, 2023, International journal of biological macromolecules.